Tracked shipping to New Zealand with premium packaging for just NZ$15 

Ship to
New Zealand
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Select your country

Americas

Europe

Rest of the world

portada FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics
FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and BiologicsFDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and BiologicsFDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics
Type
Physical Book
Publisher
Language
English
Pages
464
Format
Hardcover
Dimensions
23.1 x 15.7 x 2.8 cm
Weight
0.77 kg.
ISBN
1420073540
ISBN13
9781420073546
Edition No.
0002

FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics

Pisano, Douglas J. ; Mantus, David S. (Author) · CRC Press · Hardcover

FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics - Pisano, Douglas J. ; Mantus, David S.

New Book Imported to New Zealand
Delivery: 01 Sep - 08 Sep Shipping: 13 to 14 business days.
NZ$ 642.51
Import costs and 15% GST included in the price ✅
NZ$ 642.51

Synopsis "FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics"

Examines harmonization of the US Federal Food, Drug, and Cosmetic Act with international regulations as they apply to human drug and device development, research, manufacturing, and marketing. The Second Edition focuses on the new drug approval process, cGMPs, GCPs, quality system compliance, and corresponding documentation requirements. Written in a jargon-free style, it draws information from a wide range of resources. It demystifies the inner workings of the FDA and facilitates an understanding of how it operates with respect to compliance and product approval.FDA Regulatory Affairs: provides a blueprint to the FDA and drug, biologic, and medical device development offers current, real-time information in a simple and concise format contains a chapter highlighting the new drug application (NDA) process discusses FDA inspection processes and enforcement options includes contributions from experts at companies such as Millennium and Genzyme, leading CRO's such as PAREXEL and the Biologics Consulting Group, and the FDA Three all-new chapters cover: clinical trial exemptions advisory committees provisions for fast track

Customers reviews

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews